- Corporate Officers - F
- Farfel Gail M
Insider Trading History of Farfel Gail M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Farfel Gail M since 2015.
This trader's CIK number is 1614780.
At the time of last reporting, Farfel Gail M was the Chief Executive Officer of Promis Neurosciences Inc.. (stock ticker symbol PMN).
Also see all insider trading activities at Promis Neurosciences Inc..
Note that in the past
Farfel Gail M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Marinus Pharmaceuticals Inc (MRNS) by Farfel Gail M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | MRNS | 0 | $0 | 30,000 | $284,520 | 30,000 | $31,200 |
Yearly summary of insider trading at Promis Neurosciences Inc. (PMN) by Farfel Gail M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | PMN | 2,000 | $10,640 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Durect Corp (DRRX) by Farfel Gail M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | DRRX | 100,000 | $39,813 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Farfel Gail M
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ZGNX | 0 | $0 | 0 | $0 | 5,156 | $0 |
| 2020 | ZGNX | 0 | $0 | 2,573 | $72,584 | 12,407 | $0 |
| 2019 | ZGNX | 0 | $0 | 3,446 | $179,192 | 1,625 | $0 |
| 2018 | ZGNX | 0 | $0 | 26,079 | $1,235,082 | 25,961 | $362,415 |
Insider trading activities at 4 companies by Farfel Gail M:
1. Marinus Pharmaceuticals Inc (MRNS)
2. Promis Neurosciences Inc. (PMN)
3. Durect Corp (DRRX)
4. Zogenix, Inc. (ZGNX)
Table 1. Insider trading of Marinus Pharmaceuticals Inc (MRNS) by Farfel Gail M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-04-21 | MRNS | Sale | 30,000 | 9.48 | 284,520 |
| 2015-04-21 | MRNS | Option Ex | 30,000 | 1.04 | 31,200 |
Table 2. Insider trading of Promis Neurosciences Inc. (PMN) by Farfel Gail M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-14 | PMN | Buy | 1,000 | 4.94 | 4,940 |
| 2022-12-06 | PMN | Buy | 1,000 | 5.70 | 5,700 |
Table 3. Insider trading of Durect Corp (DRRX) by Farfel Gail M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-16 | DRRX | Buy | 25,300 | .39 | 9,816 |
| 2022-05-18 | DRRX | Buy | 29,911 | .41 | 12,203 |
| 2022-05-13 | DRRX | Buy | 9,250 | .40 | 3,700 |
| 2022-05-12 | DRRX | Buy | 1,500 | .39 | 585 |
| 2022-05-11 | DRRX | Buy | 9,950 | .40 | 3,970 |
| 2022-05-10 | DRRX | Buy | 2,339 | .41 | 949 |
| 2022-05-09 | DRRX | Buy | 17,500 | .40 | 6,912 |
| 2022-05-10 | DRRX | Buy | 4,250 | .40 | 1,678 |
Table 4. Insider trading of Zogenix, Inc. (ZGNX) by Farfel Gail M
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-15 | ZGNX | Option Ex | 5,156 | .00 | 0 |
| 2020-06-25 | ZGNX | Option Ex | 8,750 | .00 | 0 |
| 2020-05-12 | ZGNX | Sale | 2,573 | 28.21 | 72,584 |
| 2020-03-15 | ZGNX | Option Ex | 3,657 | .00 | 0 |
| 2019-08-22 | ZGNX | Sale | 3,446 | 52.00 | 179,192 |
| 2019-03-15 | ZGNX | Option Ex | 1,625 | .00 | 0 |
| 2018-10-04 | ZGNX | Option Ex | 6,961 | 13.96 | 97,175 |
| 2018-10-04 | ZGNX | Sale | 6,961 | 43.26 | 301,111 |
| 2018-09-04 | ZGNX | Sale | 7,000 | 47.74 | 334,166 |
| 2018-09-04 | ZGNX | Option Ex | 7,000 | 13.96 | 97,720 |
| 2018-08-08 | ZGNX | Option Ex | 7,000 | 13.96 | 97,720 |
| 2018-08-08 | ZGNX | Sale | 7,000 | 52.78 | 369,495 |
| 2018-06-12 | ZGNX | Sale | 5,118 | 45.00 | 230,310 |
| 2018-06-12 | ZGNX | Option Ex | 5,000 | 13.96 | 69,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Farfel Gail M
(Chief Executive Officer of Promis Neurosciences Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.